Antisense oligonucleotides targeting SMN2-pre-mRNA (SMN-AONs) have achieved long-time rescue of severe SMA mice (Smn−/−SMN2+/0) (11). The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.